INDEXVOL. 112. NO. 1–12. 2004
ACE-inhibitor 686
actin 79
Actinobacillus actinomycetemcomitans 674
acute bacterial infection 753
adenoma 29
adenomyomatous hyperplasia 218
adhesion molecules 390
adrenal 551
AFLP 210
allergic rhinitis 172
allergy 21
alpha-inhibin 384
ampicillin resistance 291
Anaplasma phagocytophilum 239
angiogenesis 201, 257, 402, 413, 431, 450, 481, 508, 585
angiogenesis inhibitors 496
animals 239
annexin V 109
antiangiogenesis 201
antiangiogenic therapy 496
antibiotic resistance; 930
antibiotic susceptibility 886
antibodies 34, 74
anti-edema: 605
antimicrobial resistance 159, 815
apoptosis 330, 595, 656
Apoptosis genes 598
ascites 585
astrocytic tumors 257
atherosclerosis 598
axillary lymph node dissection 264
axillary staging 264
azoxymethane 319
bacteria 753
bacterial diagnostics 930
Bartonella spp;, 16S rDNA 336
basement membrane 450
biomaterial infections 109
bladder cancer 148
blocky collagen 141
body mass index 349
Borrelia serology 74
breast cancer 123, 264, 349
bronchiectasis 218
cancer 89, 450, 595
Candida glabrata 283
capillary 686
carcinogen 319
carcinoma in situ 79
caspase-2 330
caspase-6 330
caspase-7 330
α-catenin 390
β-catenin 49, 390
γ-catenin 49
cauda equina 141
CD99 384
celiac disease 651
cell proliferation 225
cellular immune response 271
Chalkley 413
characterisation 771
chemiluminescence 109
chemokine receptors 481
chemokines 481
chemotherapy 201
chromogranin A 663
chromogranin B 663
chromogranin C 663
chronic obstructive pulmonary disease 299
class II HLA 271
clear cell meningioma 141
clear cell sugar tumor 98
clinical microbiology 856
c-Myc 49
collagen content in tonsils 248
collagen, integrins 450
collagen types 598
colon 3
colon cancer 49, 319, 595
colon tumor 233
commercial kits 74
common cold 172, 605
connexin 79
cortical blood flow 192
counter-current flow 192
CPB 133
cribriform-morular variant 275
Cryptosporidium hominis 309
Cryptosporidium parvum 309
C. trachomatis 771
cyclin A 39
cyclin D1 49
cytokeratin 79
cytolethal distending toxin 674
cytology 148
DA rats 651
detection 728
diagnosis 148, 585
diagnosis 771
diagnostics 808, 908
diagnostic tools 898
diarrhea 309
diffuse sclerosing variant 275
DNA extraction 342
drug resistance 728, 838
EAE 651
E-cadherin 390, 560
E. coli 569
endogenous angiogenesis inhibitors 496
endosalpingiosis 45
endothelial progenitor cells 402
Enterococcus faecium 291
epidemiological marker 753
epidemiology 908
epithelial injury 225
epithelioid angiomyolipoma 612
EPSPS 21
ERK 233
Escherichia coli 159
esophagus 29
estrogen receptor 349
experimental allergic encephalomyelitis 651
expression 89
extraadrenal 551
extracellular matrix 450
FADD 595
familial 153
FATWO 390
fibromyxoma 304
fibrous tumor 304
fibula 617
fingerprinting 210
FISH 856
foamy histiocyte 3
food-borne bacterial pathogens 908
Francisella tularensis 898
ganglioneuroma 153
gastric cancer 330
gastrointestinal stromal tumor 304
gene sequences 239
genetic methods 815
genomic islands (GEIs) 930
gluten-free diet 651
GM 21
grading 560
green fluorescent protein 441
growth factor 539
growth factor receptor 539
gyrA 165
gyrB 165
HA 526
haemolysin 283
haemolysis 283
Haemophilus influenzae 299
hCG 79
head and neck 560
Helicobacter pylori 34
histo-blood group ABO antigen 11
histogenesis 183
histology 119
histopathology 560
HLP gene 283
homocysteine 598
HuIFN-α 172
human adrenal medulla 663
IL-12 271
IL-8 172
imaging 441
immunohistochemistry 3, 29, 39, 49, 123, 183, 257, 390, 663
immunohistochemstry 588
immunomorphology 248
inclusions 29
India 159
indirect immunofluorescence 299
inflammation 109, 133
inhibin 79
integrin 79, 560
integron 159
interstitium 686
in vitro 172
in vivo 441
kidney 686
Ki-67 390
laminin 79
lectin histochemistry 183
Legionella pneumophila 210
leiomyosarcoma 105
leprosy patients 271
leukocyte trafficking 526
lipid 3
lithium 686
liver 612
lower respiratory tract infection 713
lung 218
Lyme disease 74
lymphangiogenesis 526, 539
lymphatics 463
lymph node metastases 264
lymph node status 349
LYVE-1 526
MALDI-TOF; 856
malignancy grading 663
malignant 551
malignant mesenchymoma 617
MAP kinase 233
mast cells 257
MEK 233
melanoma 508
melting temperature 239
meningitis 753
Merkel cell carcinoma 39
mesenchymal chondrosarcoma 384
mesentery 105
metronomic chemotherapy 496
metronomic treatment 201
microsatellites 148
microvessel density 413
MMP 450
molecular diagnosis 753
molecular genetic methods 771
molecular genetic methods 908
molecular methods 838
molecular techniques 728
morules 275
MS 651
mucoid bodies 29
multi-color 441
multilocular cyst renal cell carcinoma 183
multiple sclerosis 651
mutation 588
mutations 165
mycobacteria 728
myocardial fibrosis 222
myocarditis 222
myosin 79
nalidixic acid resistance 165
neuroblastoma 153
neuron-specific enolase 105
neuropilin-1 257
neutrophils 133
new E. coli O groups 569
N. gonorrhoeae 771
nitric oxide 358
nitric oxide synthase 358
novel food. 21
nucleic acid amplification test 713
oligochromatography 342
oral squamous cell carcinoma 11
osteochondrorhabdomyosarcoma 617
osteosarc 617
outbreak 210
overexpression 588
oxidative stress 123
paclitaxel 201
papillary endothelial hyperplasia 314
paraganglioma 551
parC 165
parE 165
paresis 651
pathogenicity islands (PAIs) 930
patient genotyping 886
pbp5 291
PCR 342, 713, 753, 808
PEComa 98, 612
performance 74
periodontal connective tissue cells 674
peritubular tissue 79
perivascular epithelioid cell tumor 98
pheochromocytoma 551, 663
phosphorylation 233
piglets 133
plaque formation 598
platelets 133
pneumonia 299, 713
polycystic kidney disease 358
polyp 3
population. 34
post-tonsillectomy bacteremia 248
potentially malignant lesions 11
pregnancy 159
primary neuroendocrine carcinoma of the skin 39
progesterone receptor 349
prognosis 49, 141, 349
prostate 89
proteases 450
proteolysis 463
p38-mitogen-activated-protein-kinase 109
p53 123
p63 656
quantitation 413
rat 119
rat model 319
rats 686
real-time 441
real-time PCR 239
red fluorescent protein 441
region-specific antibodies 663
reinfection 309
renal ischemia 192
review 642
rhinitis 605
rhinovirus 172
routine 148
RT-PCR 283
Rubella virus 656
Salmonella Hadar 165
sample preparation 808
secondary effects 319
secretogranin II 663
seminoma 79
sentinel node biopsy 264
sequencing 165
seroprevalence 34
shigatoxin 569
signal transduction 225
small mammals 336
smooth muscle cells 598
smooth muscle proliferation 218
soft tissue 98
somatic mutation 595
soybean 21
spiked blood samples 342
squamous cell carcinoma 560
standardization 808
stomach 304
stomach cancer 595
sublingual gland 119
subtyping 908
syndecan-1 89
synovial haemangioma 314
TaqMan 342
T cells 642
tendon sheath 314
thiazide diuretics 686
thioredoxin 123
thioredoxin reductase. 123
thyroidectomy 119
thyroid gland 384
thyroid papillary carcinoma 275
tissue microarray 330, 588
TNF-α 172
tonsillar sclerosis 248
Toxoplasma gondii 342
transplanted ileum 309
treatment 605, 886
Treg cells 642
Tropheryma whippelii 222
troxerutin 172, 605
tubular necrosis 192
tubules 686
tularemia; typing 898
tumorigenesis 233
tumor-like 45
tumour angiogenic ability (TAA) 431
tumour metastasis 526
type 1 diabetes mellitus 651
tyrosine phosphorylation 225
ultrastructure 98
urinary tract infection 159
uterus. 45
validation 808
vascular endothelial growth factor 539
vascular survival ability (VSA) 431
vasculogenesis 508
vasculogenic mimicry 508
VEGF 585
VEGF-A 201
VEGF-C 463
VEGF-D 463
VEGF receptors 402
verocytotoxin 569
verocytotoxin-producing E. coli (VTEC) 569
vimentin 79
virulence 930
virulence determinants 886
virus-encoded chemokine elements 481
xanthoma 3
6S rRNA 856
